JOINT FILING AGREEMENT
Exhibit
2
In
accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as
amended, each of the undersigned Reporting Persons hereby agrees to the joint
filing, along with all other such Reporting Persons, on behalf of each of them
of a statement on Schedule 13G (including amendments thereto) with respect to
the Class A Common Stock, $0.014 par value, of Medicis Pharmaceutical
Corporation, and that this Agreement be included as an Exhibit to such joint
filing. This Agreement may be executed in any number of counterparts,
all of which taken together shall constitute one and the same
instrument.
IN
WITNESS WHEREOF, each of the undersigned hereby executes this Agreement as of
this 7th day of
August, 2009.
|
|||
|
By:
|
X.
X. Xxxx & Co., L.P., as
managing
member
|
|
|
|
|
|
By: | /s/ Xxxxxxxx Xxxxx | ||
|
|
|
Xxxxxxxx
Xxxxx
Chief
Compliance Officer
|
X. X. Xxxx & Co., L.P. | ||
|
|
|
By: | /s/ Xxxxxxxx Xxxxx | |
Xxxxxxxx
Xxxxx
Chief
Compliance Officer
|
Xxxxx X. Xxxx | ||
|
|
|
By: | /s/ Xxxxxxxx Xxxxx | |
Xxxxxxxx
Xxxxx
Attorney-in-Fact
for Xxxxx X.
Xxxx
|